NO306196B1 - Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en <beta>-adrenerg antagonist og anvendelse av disse - Google Patents

Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en <beta>-adrenerg antagonist og anvendelse av disse

Info

Publication number
NO306196B1
NO306196B1 NO933714A NO933714A NO306196B1 NO 306196 B1 NO306196 B1 NO 306196B1 NO 933714 A NO933714 A NO 933714A NO 933714 A NO933714 A NO 933714A NO 306196 B1 NO306196 B1 NO 306196B1
Authority
NO
Norway
Prior art keywords
beta
combinations
carboxylic acid
anhydrase inhibitor
adrenergic antagonist
Prior art date
Application number
NO933714A
Other languages
English (en)
Norwegian (no)
Other versions
NO933714L (no
NO933714D0 (no
Inventor
John J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27103852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO306196(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO933714L publication Critical patent/NO933714L/no
Publication of NO933714D0 publication Critical patent/NO933714D0/no
Publication of NO306196B1 publication Critical patent/NO306196B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO933714A 1991-04-17 1993-10-15 Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en <beta>-adrenerg antagonist og anvendelse av disse NO306196B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68671891A 1991-04-17 1991-04-17
US83491392A 1992-02-13 1992-02-13
PCT/US1992/002903 WO1992018124A1 (fr) 1991-04-17 1992-04-09 COMPOSITIONS OPHTALMIQUES RENFERMANT DES COMBINAISONS D'UN INHIBITEUR D'ANHYDRASE CARBONIQUE ET D'UN ANTAGONISTE β-ADRENERGIQUE

Publications (3)

Publication Number Publication Date
NO933714L NO933714L (no) 1993-10-15
NO933714D0 NO933714D0 (no) 1993-10-15
NO306196B1 true NO306196B1 (no) 1999-10-04

Family

ID=27103852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933714A NO306196B1 (no) 1991-04-17 1993-10-15 Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en <beta>-adrenerg antagonist og anvendelse av disse

Country Status (24)

Country Link
EP (1) EP0509752B1 (fr)
JP (1) JP2527513B2 (fr)
KR (1) KR920019348A (fr)
CN (1) CN1073421C (fr)
AT (1) ATE182787T1 (fr)
AU (1) AU648659C (fr)
CA (1) CA2065965C (fr)
CH (1) CH0509752H1 (fr)
CY (1) CY2146B1 (fr)
CZ (1) CZ285129B6 (fr)
DE (3) DE69229688C5 (fr)
DK (1) DK0509752T3 (fr)
ES (1) ES2133304T3 (fr)
GR (1) GR3031467T3 (fr)
IE (1) IE921240A1 (fr)
IL (1) IL101537A (fr)
LU (1) LU90506I2 (fr)
MX (1) MX9201785A (fr)
NL (1) NL990041I2 (fr)
NO (1) NO306196B1 (fr)
RO (1) RO113612B1 (fr)
SK (1) SK282039B6 (fr)
WO (1) WO1992018124A1 (fr)
YU (1) YU39392A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932572A (en) * 1992-02-21 1999-08-03 Alcon Laboratories, Inc. Topical anti-glaucoma compositions
WO1993016701A2 (fr) * 1992-02-21 1993-09-02 Alcon Laboratories, Inc. Compositions antiglaucome a usage local comprenant des inhibiteurs d'anhydrase carbonique et de beta-bloquants
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
FI981473L (fi) * 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
CN100345594C (zh) * 2004-01-19 2007-10-31 无锡杰西医药科技有限公司 乙酰唑胺滴眼液
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
KR101820184B1 (ko) 2010-07-29 2018-01-18 알러간, 인코포레이티드 방부제가 없는 비마토프로스트 및 티몰롤 용액
JP5893204B1 (ja) * 2015-02-23 2016-03-23 参天製薬株式会社 防腐効果のある医薬の組合せ
JP6132968B1 (ja) * 2016-01-29 2017-05-24 参天製薬株式会社 ドルゾラミド、高分子およびホウ酸を含有する医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use

Also Published As

Publication number Publication date
NL990041I1 (nl) 2000-02-01
CN1066781A (zh) 1992-12-09
CY2146B1 (en) 2002-06-21
SK282039B6 (sk) 2001-10-08
EP0509752A3 (en) 1993-03-03
DE69229688T4 (de) 2010-08-19
LU90506I2 (fr) 2000-03-28
DE69229688T2 (de) 2000-02-24
DE69229688D1 (de) 1999-09-09
RO113612B1 (ro) 1998-09-30
CZ209893A3 (en) 1994-06-15
DK0509752T3 (da) 1999-12-06
CA2065965C (fr) 1998-06-16
GR3031467T3 (en) 2000-01-31
DE10075002I1 (de) 2000-03-30
ATE182787T1 (de) 1999-08-15
DE10075002I2 (de) 2004-07-01
NO933714L (no) 1993-10-15
SK110393A3 (en) 1994-02-02
MX9201785A (es) 1992-10-01
AU648659C (en) 2008-02-14
AU1497992A (en) 1992-10-22
CZ285129B6 (cs) 1999-05-12
JPH05117167A (ja) 1993-05-14
NL990041I2 (nl) 2000-04-03
CA2065965A1 (fr) 1992-10-18
IL101537A (en) 1997-11-20
WO1992018124A1 (fr) 1992-10-29
JP2527513B2 (ja) 1996-08-28
DE69229688C5 (de) 2010-10-21
KR920019348A (ko) 1992-11-19
IL101537A0 (en) 1992-12-30
EP0509752A2 (fr) 1992-10-21
NO933714D0 (no) 1993-10-15
ES2133304T3 (es) 1999-09-16
CN1073421C (zh) 2001-10-24
IE921240A1 (en) 1992-10-21
AU648659B2 (en) 1994-04-28
EP0509752B1 (fr) 1999-08-04
YU39392A (sh) 1995-12-04
HK1009251A1 (en) 1999-05-28
CH0509752H1 (fr) 2012-11-30

Similar Documents

Publication Publication Date Title
FI921924A7 (fi) Portabel koldioxidmonitor
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
IT8941653A0 (it) Dispositivo per la correzione delle anomalie di rifrazione dell&#39;occhio.
NO306196B1 (no) Oftalmiske preparater omfattende kombinasjoner av en karbonsyreanhydraseinhibitor og en &lt;beta&gt;-adrenerg antagonist og anvendelse av disse
EP0276543A3 (fr) Emploi de buspirone pour l&#39;amélioration de la mémoire à court terme
IT1226551B (it) Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita&#39; verso l&#39;alfa- fetoproteina e loro impiego in campo diagnostico
DK0679717T3 (da) Opløselig interferon-receptor og fremstilling og anvendelse heraf
DK1431391T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
ATE195872T1 (de) Aufbewahren von stammzellen
FI954138L (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
FR2733418B1 (fr) Nouvelles associations comprenant du (-) hydroxycitrate et presentant notamment de nouvelles activites therapeutiques
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
ITRM940160A0 (it) Procedimento e dispositivo per la riduzione dell&#39;inserimento di ossigeno in un monocristallo di silicio.
DE69224290D1 (de) Optisch aktive trifluormilchsäurederivate und flüssigkristallzusammensetzungen
IT1225800B (it) Polarizzatore doppio, per l&#39;osservazione dei cinescopi in genere
SE8401907D0 (sv) New phenoxypropanol amine salts and pharmaceutical preparations thereof
ATE106088T1 (de) Peptide und deren verwendung in der therapie.
IT1229511B (it) Dispositivo per la cura chirurgica dell&#39;astigmatismo
DE69028466D1 (de) Optisch aktive, Fluor enthaltende Alkohole und Flüssigkristallabkömmlinge davon
ITMI910913U1 (it) Portaombrelli portatile, in particolare per l&#39;utilizzo all&#39;interno di autovetture
IT9021076A0 (it) &#34;nuovo uso del bendazac e dei suoi sali farmaceuticamente accettabili&#34;
IT229616Y1 (it) Cartello per l&#39;impiego in vetrine e simili

Legal Events

Date Code Title Description
MK1K Patent expired